Blog Archive

Friday, March 12, 2021

OCUGEN NEWS

 Ocugen Inc NASDAQ: OCGN

Health Care : Biotechnology | Small Cap Value
Company profile

New! We've created a page tailored for you. Click here to see the stocks overview page.

Premarket

Last Trade
$9.52
-0.08 (-0.83%)
Bid
9.50
Ask
9.52
B/A Size
1200x7100
BuySell
Closing Price
$9.60
Day's Change
0.00 (0.00%)
Bid close
9.56
Ask close
9.63
B/A Size
1200x7100
Day's High
--
Day's Low
--
Volume
309,757

Default Chart SettingsChange

Chart Style
Upper Indicators
Lower Indicators
Comparison & Events

Price (OCGN)

Open 8.30High 8.3285Low 8.06Close 8.2803/05 02:30 pm

Volume

+
-
AVG VOL (10)
VOLUME (10) 933.66KAVG VOL 1.62M03/05 02:30 pm
Market data and information provided by Morningstar.

The risk of loss in trading futures can be substantial. Clients must consider all relevant risk factors, including their own personal financial situation, before trading. Margin and level 2 options approval or higher is required. Not all account owners will qualify.

Dividends are converted to USD using the current rate of exchange at the end of the business day on the day the dividend went EX. Earnings are converted to USD using the current rate of exchange at the end of the business day on the day earnings were announced.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.

No comments:

Post a Comment

SNGX

 The future outlook for Soligenix (SNGX) stock is mixed with both potential upside and high risks. Here's an overview of what analysts ...

Labels